Federal Legislation

AADE is always working for its members at the Federal level on issues that support and promote the diabetes educator. In addition, we are constantly monitoring legislation that affects diabetes educators, diabetes education and people with diabetes. When needed, AADE takes a position on an issue. These are current pieces of federal legislation that AADE is directly involved with, supporting or opposing.

Be sure to visit our Legislative Action Center for the latest federal calls to take action!

Current AADE Federal Legislation

The Access to Quality Diabetes Education Acts - H.R. 1726/S. 1345

The "Access to Quality Diabetes Education Acts," Amends title XVIII (Medicare) of the Social Security Act to recognize state-licensed or -registered certified diabetes educators or state-licensed or -registered health care professionals who specialize in teaching individuals with diabetes to develop the necessary skills and knowledge to manage the individual's diabetic condition and are certified as a diabetes educator by a recognized certifying body. Directs the Comptroller General (GAO) to study the barriers that exist for Medicare beneficiaries with diabetes in accessing diabetes self-management training services under the Medicare program. Requires the Director of the Agency for Health Care Research and Quality of the Department of Health and Human Services (HHS) to develop a series of recommendations on effective outreach methods to educate primary care physicians and other health care providers as well as the public about the benefits of diabetes self-management training.

AADE Federal Bill Tracking

Bill # and Name




H.R. 1686

Preventing Diabetes in Medicare Act

Extends Medicare coverage for medical nutrition therapy (MNT) to individuals with pre-diabetes or those with risk factors of developing Type 2.




H.R. 1427/ S. 804

Medicare CGM Access Act of 2015

Provides coverage of continuous glucose monitoring (CGM) to type 1 under certain circumstances.




H.R. 1192/ S. 586

National Diabetes Clinical Care Commission Act

Establishes a Commission with Health & Human Services (HHS) to provide better coordination of care for people with pre-diabetes, diabetes, and the chronic disease and conditions that are associated with diabetes.




S. 84

Gestational Diabetes (GEDI) Act

Directs the Centers for Disease Control and Prevention (CDC) to develop a multi-state gestational diabetes research project to expand and enhance public health research on gestational diabetes.




S. 776

Medication Therapy Management Empowerment Act of 2015

Improves access to medication therapy management (MTM0 for beneficiaries in Part D but allowing Part D beneficiaries to become eligible for MTM as they suffer from a single chronic condition that has been shown to respond well to improved medication adherence. Specific conditions noted in statute are diabetes, as well as cardiovascular disease, COPD, and high cholesterol.




H.R. 1727

Safe Needle Disposal Act of 2015

Provides coverage for supplies associated with the injection of insulin, of containment, removal, decontamination and removal of home-generated needles, syringes, and other sharps through a sharp container.




H.R. 6

21st Century Cures Act

Intended to modernize the biomedical innovation infrastructure and accelerate the pace of cures.




S. 1131/ H.R. 2102

Medicare Diabetes Prevention Act

Expands a proven, community-based prevention program to help seniors prevent type-2 diabetes by allowing Medicare to provide the National Diabetes Prevention Program to seniors.




H.R. 1600

Patients’ Access to Treatments Act of 2015

Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure. Prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier. Applies the non-preferred brand drug tier for which beneficiary cost-sharing is lowest, if a formulary used by the health plan contains more than one non-preferred brand drug tier.




H.R. 3081/ S. 1778

Tele-health for Medicare (TELE-MED) Act of 2015

Removes barriers to the interstate practice of telemedicine within Medicare.




H.R. 4209

Minority Diabetes Initiative Act

Establishes an initiative to provide grants to physicians and community-based organizations that work with and for minority populations for a variety of diabetes-related health services.

In This Section